122 related articles for article (PubMed ID: 603503)
1. Clinical effect of O-betahydroxyethyl-rutosides (HR) in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Grabowski R; Myśliwiec M; Korfel B
Bibl Anat; 1977; (16 Pt 2):152-4. PubMed ID: 603503
[No Abstract] [Full Text] [Related]
2. Clinical effect of high doses of o-betahydroxyethyl-rutosides in patients with occlusive arterial disease.
Bielawiec M; Lukjan H; Kiersnowska-Rogowska B; Dabrowski S
Bibl Anat; 1979; (18):378-81. PubMed ID: 496871
[No Abstract] [Full Text] [Related]
3. The effect of O-betahydroxyethyl-rutosides (HR) on the number of platelet-leukocyte aggregates in patients with occlusive arterial disease.
Bielawiec M; Kiersnowska-Rogowska B; Dabrowski S; Lukjan H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(1):103-8. PubMed ID: 88383
[TBL] [Abstract][Full Text] [Related]
4. The effect of HR (O-Beta-Hydroxyethylo-Rutoside, Venoruton) on the deformability of erythrocytes in patients with arteriosclerosis obliterans of lower limbs.
Lukjan H; Rość D; Chyzy R; Bodzenta A; Szpak A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):191-6. PubMed ID: 2581865
[TBL] [Abstract][Full Text] [Related]
5. The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.
Roztocil K; Oliva I; Prerovský I; Linhart J
Cor Vasa; 1989; 31(2):128-33. PubMed ID: 2663343
[TBL] [Abstract][Full Text] [Related]
6. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
[No Abstract] [Full Text] [Related]
7. A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers.
Mann RJ
Br J Clin Pract; 1981 Feb; 35(2):79-81. PubMed ID: 7020736
[No Abstract] [Full Text] [Related]
8. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
Stegmann W; Hubner K; Deichmann B; Muller B
Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
[TBL] [Abstract][Full Text] [Related]
9. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
Forconi S; Guerrini M
Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
[No Abstract] [Full Text] [Related]
10. [Effects of proxazole on patients with obliterating arteriopathy of the lower limbs].
Saponaro A; Russo R; Tomei F; Giordano M; Dragagna G; Barbato G
Clin Ter; 1979 Dec; 91(6):585-92. PubMed ID: 544162
[No Abstract] [Full Text] [Related]
11. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
12. [Effect of Venoruton on the lower-leg volume in normal persons and in patients with venous-flow disorders].
Bopp J
Med Welt; 1977 Oct; 28(41):1660-4. PubMed ID: 927128
[No Abstract] [Full Text] [Related]
13. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
Vaccaro E; Solitro A; Barba C
Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
[No Abstract] [Full Text] [Related]
14. [On the therapy of peripheral organo-angiopathies using Progresin].
Horn HJ
Med Klin; 1968 Aug; 63(35):1377-8 passim. PubMed ID: 5682033
[No Abstract] [Full Text] [Related]
15. [Statins in the treatment of patients with arterial occlusive disease of the lower extremities].
Mayer O; Hromádka M
Vnitr Lek; 2001 Oct; 47(10):664-9. PubMed ID: 11789002
[TBL] [Abstract][Full Text] [Related]
16. Improvement of subcutaneous nutritional blood flow in the forefoot by hydroxyethylrutosides in patients with arterial insufficiency: case studies.
Jelnes R; Gaardsting O; Holm A
Angiology; 1986 Mar; 37(3 Pt 1):198-202. PubMed ID: 3706821
[TBL] [Abstract][Full Text] [Related]
17. [Benzopyrone in the therapy of postreconstructive edema. A clinical double-blind study].
Becker HM; Niedermaier G; Orend KH
Fortschr Med; 1985 Jun; 103(21):593-6. PubMed ID: 4018687
[No Abstract] [Full Text] [Related]
18. The effect of hydroxyethylrutoside (HR) on peripheral blood flow: a preliminary report.
Fitzgerald DE; Butterfield WJ; Keates JS; Hodges M
Bibl Anat; 1969; 10():600-5. PubMed ID: 5407421
[No Abstract] [Full Text] [Related]
19. Vasodilator drugs in the treatment of peripheral arterial insufficiency.
Hansteen V; Lorentsen E
Acta Med Scand Suppl; 1974; 556():3-62. PubMed ID: 4366049
[No Abstract] [Full Text] [Related]
20. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
Baldoni E
G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
